Paydirt
CRVS
Ticker

Corvus Pharmaceuticals, Inc.

CRVS · Healthcare · Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development of product candidates that precisely t…

Corvus Pharmaceuticals, Inc. (CRVS), in the Healthcare sector, has 1 disclosed filing on Paydirt over the trailing twelve months from 1 corporate insider: 1 purchase and 0 sales. Filers took a median of 4 days from execution to disclosure, and the most recent trade was executed Jun 11 and filed Jun 15. The most active filer was David Scott Moore with 1 filing. Data as of Nov 7 2026.

Add to watchlist
Filings, ttm
1
1 buy · 0 sells
Traders, ttm
1
1 insider
Volume, ttmiDollar value disclosed in the window
$250K
estimated for Congress, as filed for insiders
Median delay
4d
execution to disclosure
Last traded
Jun 11
Filed Jun 15
ADViAverage daily dollar volume
$19.4M
market data
Share price · 12M
$14.15 (+78.9%)
$25.52$16.01$6.50Nov 10 2025Mar 25Aug 5

Adjusted for splits and dividends.

Volume by month
$9.8M$4.9M$0Dec 2024Jun 2025Dec 2025Jun 2026Jul 2025 · sells $9.8MJun 2026 · buys $250K
Buys $250K Sells $9.8M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed · past 24 months
DM David Scott Moore Director 1 filing · 1 buy, 0 sales OL Orbimed Advisors Llc Director 1 filing · 0 buys, 1 sale PT Peter A. Thompson Director 1 filing · 0 buys, 1 sale
Recent filings
David Scott MoorePURCHASE Director $250K
21,700 sh × $11.53
Exec Jun 11
Filed Jun 15 · 5:12 PM ET Peter A. ThompsonSALE Director $4.9M
1,176,332 sh × $4.16
Exec Jun 27 2025
Filed Jul 1 2025 · 5:30 PM ET Orbimed Advisors LlcSALE Director $4.9M
1,176,332 sh × $4.16
Exec Jun 27 2025
Filed Jul 1 2025 · 5:30 PM ET